<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>HIV-infected individuals have a significantly increased risk of developing an aggressive B-cell Non-Hodgkin <z:hpo ids='HP_0002665'>Lymphoma</z:hpo> relative to HIV(-) persons </plain></SENT>
<SENT sid="1" pm="."><plain>Due to their aggressive nature, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-related <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (ARL) can also be more difficult to classify </plain></SENT>
<SENT sid="2" pm="."><plain>Genetic abnormalities are known to play a significant role in HIV(-) <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>To aid in case classification and identify key pathogenetic events in ARL, we analyzed gene expression data and somatic DNA copy number changes by high-resolution array comparative genomic hybridization in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> from 20 B-cell derived ARL (B-ARL) patients </plain></SENT>
<SENT sid="4" pm="."><plain>Gene expression-based predictors robustly classified the B-ARL cases, distinguishing Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and identifying activated B-cell like and germinal center B-cell like molecular subtypes of diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Array comparative genomic hybridization analysis revealed 13 recurrent losses and 16 recurrent gains in the B-ARL cases, including gain of 19p13.2 and loss of 16q23, not previously reported in B-ARL </plain></SENT>
<SENT sid="6" pm="."><plain>The WWOX <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene was characterized as a candidate gene for the 16q23.1 locus and showed gene silencing or truncated transcript in 9 of 16 cases </plain></SENT>
<SENT sid="7" pm="."><plain>These data demonstrate the ability to molecularly classify B-ARL <z:hpo ids='HP_0002665'>lymphomas</z:hpo> by gene expression and identified DNA copy number alterations targeted in B-ARL </plain></SENT>
</text></document>